Skip to main content
. 2019 Sep;11(9):4039–4048. doi: 10.21037/jtd.2019.08.109

Table 2. Summary of findings from articles evaluating the clinical significance of ETT in myasthenia gravis.

Author [year] Country Surgical approach Total No. No. with thymoma [%] No. with ETT [%] Clinical significance
Ashour [1995] (24) Saudi Arabia Transcervical-transsternal ThX 38 0 [0] 15 [40] +
Mineo [2000] (25) Belgium Left-sided VATS 31 4 [13] 10 [32]
Ozdemir [2002] (26) Turkey Median sternotomy 61 15 [25] 17 [28] +
Essa [2003] (27) Saudi Arabia Transcervical-transsternal ThX 30 0 [0] 10 [33] +
El-Medany [2003] (28) Saudi Arabia Transcervical-transsternal ThX 100 7 [7] 27 [27] +
Zielinski [2004] (30) Poland Median sternotomy 58 0 [0] 33 [57]
Ponseti [2008] (32) Spain Median sternotomy 83 0 [0] 35 [42] +
Ambrogi [2012] (37) Italy Median sternotomy 106 0 [0] 51 [48] +
Marulli [2013] (39) Italy Left-sided RATS 100 8 [8] 26 [26]

+ means that the presence of ectopic thymic tissue is associated with poor outcome of myasthenia gravis after thymectomy. − means that the presence of ectopic thymic tissue is not associated with the clinical outcome of myasthenia gravis after thymectomy. ThX, thymectomy; ETT, ectopic thymic tissue; VATS, video-assisted thoracoscopic surgery; RATS, robotic-assisted thoracoscopic surgery.